Loading clinical trials...
Loading clinical trials...
A Phase I/II Study of Sorafenib and Everolimus in Patients With Advanced Solid Tumors and Gemcitabine-Refractory Metastatic Pancreatic Cancer
Conditions
Interventions
sorafenib tosylate
everolimus
+3 more
Locations
2
United States
University of Colorado at Denver Health Sciences Center
Aurora, Colorado, United States
Roswell Park Cancer Institute
Buffalo, New York, United States
Start Date
August 1, 2009
Primary Completion Date
August 1, 2011
Completion Date
December 1, 2012
Last Updated
September 13, 2022
NCT07098598
NCT02047474
NCT01835041
NCT00031694
NCT01643499
NCT01846520
Lead Sponsor
Roswell Park Cancer Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions